다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

MGRX

Mangoceuticals (MGRX)

Mangoceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:MGRX

일자	시간	출처	헤드라인	심볼	기업
2024/06/11	02:28	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MGRX	Mangoceuticals Inc
2024/06/06	21:30	GlobeNewswire Inc.	MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology	NASDAQ:MGRX	Mangoceuticals Inc
2024/06/06	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MGRX	Mangoceuticals Inc
2024/06/06	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MGRX	Mangoceuticals Inc
2024/06/06	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MGRX	Mangoceuticals Inc
2024/06/05	05:00	GlobeNewswire Inc.	MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont Technologies	NASDAQ:MGRX	Mangoceuticals Inc
2024/06/04	21:00	GlobeNewswire Inc.	MangoRx to Introduce “MOJO” Pharmaceutical Compounded Formula Featuring Enclomiphene Citrate and Pregnenolone for Treatment of Low Testosterone and Male Hormone Imbalances	NASDAQ:MGRX	Mangoceuticals Inc
2024/05/28	21:30	GlobeNewswire Inc.	Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Distribution in Mexico and Latin American Markets	NASDAQ:MGRX	Mangoceuticals Inc
2024/05/23	21:30	GlobeNewswire Inc.	MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts	NASDAQ:MGRX	Mangoceuticals Inc
2024/05/21	21:30	GlobeNewswire Inc.	MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications	NASDAQ:MGRX	Mangoceuticals Inc
2024/05/17	05:40	GlobeNewswire Inc.	MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market Penetration	NASDAQ:MGRX	Mangoceuticals Inc
2024/05/17	02:59	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:MGRX	Mangoceuticals Inc
2024/05/16	22:19	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:MGRX	Mangoceuticals Inc
2024/05/16	05:52	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:MGRX	Mangoceuticals Inc
2024/05/14	22:00	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:MGRX	Mangoceuticals Inc
2024/05/10	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:MGRX	Mangoceuticals Inc
2024/05/07	06:32	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:MGRX	Mangoceuticals Inc
2024/05/07	05:43	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:MGRX	Mangoceuticals Inc
2024/05/02	21:00	GlobeNewswire Inc.	Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq’s Minimum Stockholders’ Equity Requirement	NASDAQ:MGRX	Mangoceuticals Inc
2024/04/25	21:30	GlobeNewswire Inc.	Mangoceuticals Acquires Global Patent Portfolio to Revolutionize Preventive Care	NASDAQ:MGRX	Mangoceuticals Inc
2024/04/12	21:45	GlobeNewswire Inc.	Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products	NASDAQ:MGRX	Mangoceuticals Inc
2024/03/12	22:00	GlobeNewswire Inc.	MangoRx Officially Launches ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment	NASDAQ:MGRX	Mangoceuticals Inc
2024/02/20	23:00	GlobeNewswire Inc.	MangoRx Launches Direct-To-Clinics Sales Division to Drive and Fuel Customer Acquisition and Revenue Growth	NASDAQ:MGRX	Mangoceuticals Inc
2024/02/13	22:00	GlobeNewswire Inc.	MANGORX AWARDS SAN FRANCISCO TEAM FREE MANGORX ED PRODUCTS FOR ONE YEAR FOLLOWING BIG GAME LOSS TO KANSAS CITY	NASDAQ:MGRX	Mangoceuticals Inc
2024/02/06	23:00	GlobeNewswire Inc.	MANGORX TO OFFER THE BIG GAME’S LOSING TEAM A FREE ONE YEAR SUPPLY OF ITS ED PRODUCT, MANGO, TO HELP RAISE… SPIRITS	NASDAQ:MGRX	Mangoceuticals Inc
2024/02/05	22:50	GlobeNewswire Inc.	MangoRx Accepting Pre Orders for its “PRIME”, by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Product	NASDAQ:MGRX	Mangoceuticals Inc
2024/01/19	22:00	GlobeNewswire Inc.	MangoRx’s Brand and Products to be Featured by Barstool Sports in Week of Programming Around the Biggest Sports Event of the Year on February 11	NASDAQ:MGRX	Mangoceuticals Inc
2023/12/16	00:39	GlobeNewswire Inc.	Mangoceuticals, Inc. Announces Pricing of $1,200,000 Public Offering	NASDAQ:MGRX	Mangoceuticals Inc
2023/12/13	21:30	GlobeNewswire Inc.	MANGOCEUTICALS TO INTRODUCE “PRIME”, POWERED BY KYZATREX®️ (CIII TESTOSTERONE UNDECANOATE CAPSULES), FOR AN FDA APPROVED ORAL TESTOSTERONE REPLACEMENT THERAPY (TRT) PRODUCT	NASDAQ:MGRX	Mangoceuticals Inc
2023/12/06	22:00	GlobeNewswire Inc.	Mangoceuticals Launches MangoRx Mexico Subsidiary, Paving the Way for Over-the-Counter Retail of Erectile Dysfunction Line of Products in Latin America	NASDAQ:MGRX	Mangoceuticals Inc

검색 관련기사 보기:NASDAQ:MGRX

US Dollar vs Sterling

Verizon Communications

Energy Select Sector SPDR

Health Care Select Sector

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관